Mackenzie Financial’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,748
Closed -$18.2K 1800
2025
Q2
$18.2K Buy
18,748
+2,648
+16% +$2.2K ﹤0.01% 1680
2025
Q1
$11.4K Hold
16,100
﹤0.01% 1660
2024
Q4
$13K Hold
16,100
﹤0.01% 1689
2024
Q3
$16K Buy
+16,100
New +$22.1K ﹤0.01% 1570
2023
Q2
Sell
-14,084
Closed -$12K 1603
2023
Q1
$12K Hold
14,084
﹤0.01% 1496
2022
Q4
$18.3K Hold
14,084
﹤0.01% 1404
2022
Q3
$25K Buy
14,084
+1,175
+9% +$2.92K ﹤0.01% 1400
2022
Q2
$29K Buy
12,909
+2,540
+24% +$6.08K ﹤0.01% 1420
2022
Q1
$34K Buy
+10,369
New +$36.4K ﹤0.01% 1382
2021
Q4
Sell
-42,419
Closed -$305K 1480
2021
Q3
$305K Buy
42,419
+4,496
+12% +$33K ﹤0.01% 1132
2021
Q2
$305K Buy
+37,923
New +$320K ﹤0.01% 1066

Other funds holding OCGN

Mackenzie Financial's OCGN Position: Q3 2025 in Review

Mackenzie Financial sold out of Ocugen (OCGN) in Q3 2025, closing a stake of 18,748 shares — an estimated $18.2K sold.

Mackenzie Financial first reported a position in OCGN in Q2 2021 and held it in 11 quarters. The position peaked at $305K in Q3 2021. 97 funds tracked by Wall St. Rank hold OCGN as of Q3 2025.

  • Mackenzie Financial reported no remaining Ocugen position as of Q3 2025 after selling out during the quarter.
  • Mackenzie Financial sold 18,748 Ocugen shares in Q3 2025, an estimated $18.2K.
  • Mackenzie Financial first reported a position in Ocugen in Q2 2021 and held it in 11 quarters.
  • Mackenzie Financial's Ocugen position peaked at $305K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Ocugen as of Q3 2025.

Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.